Synapse - Katharine Hsu

Results (187)

CALGB 150905 (Alliance): Rituximab broadens the antilymphoma response by activating unlicensed NK cells

Journal Article

Du, J.; Lopez-Verges, S.; Pitcher, B. N.; Johnson, J.; Jung, S. H.; Zhou, L. L.; Hsu, K.; Czuczman, M. S.; Cheson, B.; Kaplan, L.; more...
Cancer Immunology Research (2014)

Fulltext@MSK | Save

Phenotypic and functional activation of hyporesponsive KIR(neg)NKG2A(neg) human NK-cell precursors requires IL12p70 provided by poly(I:C)-matured monocyte-derived dendritic cells

Journal Article

Curran, S. A.; Romano, E.; Kennedy, M. G.; Hsu, K. C.; Young, J. W.
Cancer Immunology Research (2014)

Fulltext@MSK | Save

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation

Journal Article

Petersdorf, E. W.; Gooley, T. A.; Malkki, M.; Bacigalupo, A. P.; Cesbron, A.; Du Toit, E.; Ehninger, G.; Egeland, T.; Fischer, G. F.; Gervais, T.; more...
Blood (2014)

Fulltext@MSK | Save

Donor activating KIR2DS1 in leukemia

Journal Article

Venstrom, J. M.; Dupont, B.; Hsu, K. C.
New England Journal of Medicine (2014)

Fulltext@MSK | Save

Development of a novel multiplex PCR assay to detect functional subtypes of KIR3DL1 alleles

Journal Article

Boudreau, J. E.; Le Luduec, J. B.; Hsu, K. C.
PLoS ONE (2014)

Fulltext@MSK | Save

High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation

Meeting Abstract

Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M.; Evans, K.; Prockop, S. E.; Scaradavou, A.; Kernan, N.; Giralt, S. A.; more...
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

BRAF V600E mutation and clonal evolution in a patient with relapsed refractory myeloma with plasmablastic differentiation

Journal Article

Bohn, O. L.; Hsu, K.; Hyman, D. M.; Pignataro, D. S.; Giralt, S.; Teruya-Feldstein, J.
Clinical Lymphoma, Myeloma and Leukemia (2014)

Fulltext@MSK | Save

Influence of killer immunoglobulin-like receptor (KIR) and HLA genotypes on outcomes after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for patients with AML and MDS: A report from the Center For International Blood and Marrow Transplant Research Immunobiology Working Committee

Meeting Abstract

Sobecks, R. M.; Gallagher, M. M.; Askar, M.; Haagenson, M. D.; Wang, T.; Spellman, S.; Lee, S. J.; Fernandez Viña, M. A.; Muller, C. R.; Verneris, M. R.; more...
Blood (2013)

Fulltext@MSK | Save

Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)